THBS-1 silencing attenuated the suppressive effect of the miR-19a inhibitor and also suppressed tumor growth and lymphatic tube formation in vivo through TBHS1-MMP9/VEGF-C signaling [146]. This evidence concerns the gene VEGFC and neoplasm.